An overview of preventive strategies for pancreatic cancer

Annals of Oncology

Volumn 10, Issue SUPPL. 4, 1999, Pages

  Levin, Bernard ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemoprevention; Pancreatic cancer; Prevention; Secondary prevention

Indexed keywords

2 NAPHTHYLAMINE; 4 BIPHENYLAMINE; ALCOHOL; AROMATIC AMINE; ASBESTOS; ASCORBIC ACID; BETA CAROTENE; CALCIUM; CHOLESTEROL; CHROMIC ACID; CYCLOOXYGENASE 2 INHIBITOR; FARNESOL; FOLIC ACID; FOSSIL FUEL; GERANIOL; ISOPRENOID; NITROSAMINE; PERILLYL ALCOHOL; PESTICIDE; POLYSACCHARIDE; PROSTAGLANDIN SYNTHASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RETINOIC ACID RECEPTOR; RUBBER; SELENIUM; TAMOXIFEN;

BREAST CANCER; CANCER SCREENING; CHEMOPROPHYLAXIS; CHROMOSOME 7Q; CONFERENCE PAPER; DIET THERAPY; HUMAN; LUNG CANCER; MOLECULAR BIOLOGY; NONHUMAN; OCCUPATIONAL EXPOSURE; ONCOGENE K RAS; PANCREAS CANCER; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION;

EID: 0032783999     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_4.S193     Document Type: Conference Paper

References (34)

1. Parkin DM, Pisani P, Ferlay J. Global Cancer Statistics. CA Cancer J Clin 1999:49:33-64.
2. Lynch HT, Smyrk T, Kern SE, et al. Familial Pancreatic Cancer: A Review. Seminars in Oncology 1996:22:251-75.
3. Whitcomb DC, Preston RA, Aston CE, et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 1996:110:1975-80.
4. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cutionic trypsinogen gene. Nat Genet 1996:14:141-5.
5. Goggins N, Schutte M, Lu J. Germlike BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Research 1996:56:5360-4.
6. Hahn SA, Kern SE Molecular genetics of exocrine pancreatic neoplasms. Surg Clin North Am 1995: 75:857-69.
7. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996:271:350-3.
8. Moskaluk CA, Hruban RH, Kern SE. P16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Research 1997: 57:2140-3.
9. IARC manographs on the evaluation of the carcinogenic risk of chemicals to humans. Tobacco Smoking, Lyon, International Agency for Research on Cancer 1986, Vol 38.
10. Anderson KE, Potter JD, Mack TM. Pancreatic Cancer. In Cancer Epidemiology and Prevention. New York, New York: Oxford University Press, Schottenfeld D, Fraumeni JF, Jr (eds), 1996:35:725-71.
11. Bueno de Mesquita HB, Maissoneuve P, Moerman CJ. Life time history of smoking and exoenine carcinoma of the pancreas: A population-based case-control study in the Netherlands. Intl J Cancer 1991:49:816-22.
12. Fuchs CS, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking the risk of pancreatic cancer. Arch Intern Med 1996:15:2255-60.
13. Cuzick J, Routledge ML, Jenkins D, et al. DNA adducts in different tissues of smokers and non-smokers. Intl J Cancer 1990:45:673-8.
14. Hecht SS, Carmella SG, Foles P, et al. Tobacco-specific nitrosanine adducts: Studies in laboratory animals and humans. Environ Health Perspect 1999: 57-63.
15. Kadlubar FF, Butler MA, Kaderlik KR, et al. Polymorphisms for aromatic amine metabolism in humans: Relevance for human carcinogenesis. Environ Health Perspect 1992:98:69-74.
16. Patrianakos C, Hoffmann D. Chemical studies on human smoke, LXIV: On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 1979; 3: 150-9.
17. Anderson KE, Hammons GJ, Kadlubar FF, et al. Metabolic activation of aromatic amines by human pancreas. Carcinogenesis 1997; 18: 1085-92.
18. Taylor JA, Umbach DM, Stephens E, et al. The role of N-acetylation polymorphisms of NAT1 and NAT2 in smoking-associated bladder cancer. Proc Am Ass Cancer Research 1995: 36:282.
19. Pancreas. In Food, Nutrition and the Prevention of Cancer: A global perspective. American Institute for Cancer Research 1997,47:176-201.
20. Steinmetz KA, Potter JD. Vegetables, fruits and cancer. II. Mechanisms. Cancer Causes Control 1991: 2:427-42.
21. Lippman SM, Lee JJ, Sabichi AL, et al. Cancer Chemoprevention: Progress and Promise. JNCI 1998: 90:1514-28.
22. Tsuji M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998: 93:705-16.
23. Kelloff GJ, Hawk ET, Karp JE, et al. Progress in clinical chemoprevention. Semin Oncol 1997: 24:241-52.
24. Burke YD, Stark MJ, Roach SC, et al. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids 1997: 32:151-6.
25. Stayrook KR, McKinzie JH, Burke YD, et al. Induction of the apoptosis promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells. Carcinogenesis 1997: 18:1655-8.
26. Greenwald P. History of Cancer Prevention and Control. In Cancer Prevention and Control. New York, New York: Marcel Dekker, Greenwald P, Kramer BS, Weed DC (eds), 1995: 1:1-8.
27. Weed DL. Causal and Preventive Inference. In Cancer Prevention and Control. New York, New York: Marcel Dekker, Greenwald P, Kramer BS, Weed DC (eds), 1995: 17:285-302.
28. Abbruzzese JL, Evans DV, Raijman I, et al. Detection of mutated C-Ki-ras in the bile of patients with pancreatic cancer. Anticancer Res 1997: 17(2A):795-801.
29. Caldas C, Hahn SA, Hruban RH, et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Research 1994: 54:3568-73.
30. Berthelemy P, Boisson M, Escorron S, et al. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 1995: 123:188-91.
31. Tada M, Omata M, Ohto M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 1996: 110:227-131.
32. Wakabayashi T, Sawabu V, Watanabe H, et al. Detection of K-ras point mutations at codon 12 in pure pancreatic juice collected 3 years and 6 months before the clinical diagnosis of pancreatic cancer. Am J Gastroenterology 1996: 91:1849-51.
33. Cahn M, Chang K, Nguyen P, Butler J. Impact of endoscopic ultrasound with fine-needle aspiration on the surgical management of pancreatic cancer. Am J Surg 1996: 172:470-2.
34. Brugge WR, Lee MJ, Kelsey PB, et al. The use of EUS to diagnose malignant involvement of portal venous system by pancreatic cancer. Gastroint Endos 1996: 43:561-7.